COA

Nitrosamine impurity regulatory storm blog banner, valsartan NDMA contamination risk guide for pharma intermediate buyers following FDA EMA nitrosamine control guidance
blog, Buyer Resources

Nitrosamine Impurity Risk in Intermediates: Guide

This guide explains three formation pathways (amine + nitrite reaction, recovered solvent contamination, and shared-equipment cross-contamination), walks through the CPCA classification framework for assessing risk levels, and provides five questions every procurement team should ask their intermediate supplier — plus four red flags to spot on a COA.

Scroll to Top

Contact us to Get the Best Product Solution